Russia aims to approve world’s first Covid-19 vaccine by mid-August


Covid-19, one word can be seen as the curse for the year 2020. Due to the rapid spread of the Coronavirus, numerous deaths and exponential growth expected, many countries have gone into lockdowns. The consequences of a virus are not only physical or financial but also psychological. However, many countries have now moved on to easing the lockdown due to the crippled economy. There are various forms of unlocking with proper guidelines to follow. Meanwhile, there is a race between medical institutions or pharmaceutical industries going on to be the first to get vaccine approval. And it looks like Russia is doing well !!

Russia says it will be the first in the world to approve the coronavirus vaccine speak mid-August (August 10), i.e. in less than two weeks. This vaccine was created by the Moscow-based Gameleya Institute. It will be approved for public use after trials on frontline health workers. After the first human trials on the vaccine ended this week, conclusions have been drawn that its use is safe and induces an immune response.

Kirill Dmitriev, who funds Russian vaccine research, said It’s a Sputnik moment. Referring to the situation of the world’s first satellite launch. The Americans were surprised when they saw Sputnik beep. It’s the same with vaccines, but this time Russia wins. The hope of the vaccine draws even closer, alive and effective!

However, there is no scientific data published by Russian researchers on its vaccine tests. Therefore, unable to verify the claimed safety or efficacy. But it will be compiled and available soon in early August. There are also some concerns about the vaccine which is still in human trials. Vaccine trials have been broken down over the words into small and large portions, but many developers know there is still a long way to go before they can be approved. Russia is pushing vaccine research to high levels, this has been observed to be due to political pressure from the Kremlin – who wants to present Russia as a world scientific force.

While some global vaccines like Moderna have already entered their third phase trials, The Russian vaccine is still working in phase two trials. However, the developers are confident that they will complete this phase by August 3 and move immediately to phase 3 trials in parallel with the vaccination of medical workers. Russian scientists claim they were able to generate the vaccine quickly because it is an advanced version of the already existing vaccine that fights a similar disease. This is the same approach used by other vaccine developers.

For example, Moderna – now in its phase three trials, built its coronavirus vaccine based on previous research on a similar disease known as MERS. This is the only reason developers were able to create vaccines in a matter of months, which usually takes years. However, the WHO says there is no approved vaccine for MERS.

The vaccine helps prevent the virus from replicating in the body by making it weaker by using human adenovirus vectors. This the vaccine offers double protection unlike any other vaccine, this means that it is made up of two vectors and that patients will receive two booster shots.

Large vaccine trials in other countries like the United States are also working on vaccine development quickly but have not yet reached the final stage. The University of Oxford, which is at the pinnacle of vaccine development, also says there is still a long way to go!

On the other hand, US, Canadian and UK researchers claim Russian spies hacked their labs in order to steal their vaccine development secrets. However, the Kremlin denied these allegations …

Not only health workers, but also Russian defense soldiers are volunteering in human trials of the coronavirus vaccine. Although many countries have entered a global pandemic situation since mid-March, Russia had its own serious coronavirus problem and was treating more than 800,000 confirmed cases.

Meanwhile, Russia also plans to produce 30 million doses of coronavirus vaccine for national purposes and 170 million doses for international purposes this year.


Please enter your comment!
Please enter your name here